Contents

Use this page to navigate through the magazine.

P3: Editor's Note
P4: Subscribe to the Xtalks Clinical Edge™ Digital Magazine
P5: How AI Is Influencing Clinical Trials: Insights from AstraZeneca's Nate Lear
P6: FDA Perspectives on Digital Health Technologies in Clinical Trials
P7: How Takeda Is Advancing Rare Disease Trials
P8: Innovating GI Therapeutics: Science, Strategy and Insight
P9. Xtalks' Resources for Life Science Professionals
P10: Redefining Neuropsychiatric Clinical Trials: Alto Neuroscience’s Precision Psychiatry Approach
P11. Get Brand Attention in Pharma/Biotech
P12: Transforming Immuno-Oncology: A Novel Approach to Targeting the Tumor Microenvironment
P13. Xtalks Job Search for Life Science Career Opportunities
P14: Harnessing the Body’s Natural Mechanisms: Aphaia Pharma’s Novel Approach to Metabolic Disease Treatment
P15. Xtalks Life Science Podcast: Stories Shaping the Future of Pharma, Biotech and Medical Devices
P16: How Digital Endpoints Are Redefining Clinical Research Strategies: Insights from DiMe
P17. How AstraZeneca Is Enhancing Rare Disease Clinical Research Through Patient Advocacy
P18. Advancing Digital Therapeutics: The Science of Software as Medicine
P19. Advancing Cancer Treatment: Clinical Trials in Oncolytic Virus Therapy
P20. Innovative Science Driving New Approaches in Obesity Drug Development
P21. Unlocking the Epigenome for Acute Liver Disease Clinical Research
P22: Type 1 Diabetes Clinical Research: The Science of Regenerative Therapeutic Cell Technology
P23: Contact Us
Cover Page
Editor's Note